Dedicated to Improving the Quality of Life and Life
Expectancy of Dogs and Cats with Chronic Kidney
Disease (CKD)
CHRONIC KIDNEY DISEASE
A common problem in companion animals
Kidney disease in its chronic presentation affects, on average, 10.8% of cats and 5.2% of dogs brought in for consultation and is a leading cause of death. The auto-destructive cycle of chronic kidney disease (CKD) begins when nephrons decline leading to azotemia and a further loss of nephrons and kidney function. The diagnosis of CKD is generally based on low urine specific gravity and increased serum urea nitrogen, creatinine and phosphorous. However, only when 75% of nephrons are no longer functional can clinical and biochemical signs of CKD be detected.
THE AUTO-DESTRUCTIVE CYCLE OF CKD
While there is no cure, it is possible to slow the progression of the condition by fighting the auto-destructive cycle of CKD. Vétoquinol offers an innovative family of products that can work individually or with other therapies, such as diet, to limit the increase of phosphatemia and reduce azotemia, improving the longevity and quality of life.
A POWERFUL AND COMPREHENSIVE LINE OF PRODUCTS FOR ADVANCED RENAL SUPPORT
Vétoquinol offers an innovative family of products – Azodyl, Epakitin and Renal K+. These powerful weapons help break the auto-destructive cycle of CKD and protect the renal health of dogs and cats better than ever.
- Demonstrated clinical efficacy
- Safe to use, even long-term
- Highly palatable
- Easy and convenient to administer for improved compliance
- Compatible with other therapies
-
References:
- North American Veterinary Research Group (NAVRG). The management of chronic kidney disease in dogs and cats. Survey conducted among 109 Veterinarians in the USA, 2005.
- Morris Animal Foundation, 1997 Animal Health Study. Denver, CO.
- Survival of cats with naturally occurring chronic renal failure: effect of dietary management, J. Elliott, J.M. Rawlings, P.J. Markwell, P.J. Barber, JSAP (2000), 41, 235-242.
- Effects of an intestinal phosphorous binder on serum phosphorous and parathyroid hormone concentration in cats with reduced renal function. S.A. Brown, M. Rickertsen, S. Sheldon, The Journal of Applied Research in Veterinary Medicine. (2008) 6:3, 155-160.





